ScoreWhy is Applied Therapeutics, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -176.30% of over the last 5 years
2
Positive results in Jun 25
- NET PROFIT(HY) Higher at USD -47.7 MM
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -97.40%, its profits have fallen by -67%
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -3.66% over the previous quarter and currently hold 9.55% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
5
Below par performance in long term as well as near term
- Along with generating -97.40% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Applied Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Applied Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Applied Therapeutics, Inc.
-86.4%
-0.46
206.28%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.29%
EBIT Growth (5y)
-176.30%
EBIT to Interest (avg)
-86.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.37
Sales to Capital Employed (avg)
-0.85
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.43
EV to EBIT
-0.02
EV to EBITDA
-0.02
EV to Capital Employed
-0.14
EV to Sales
1.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-287.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET PROFIT(HY)
Higher at USD -47.7 MM
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 107% (YoY
Here's what is working for Applied Therapeutics, Inc.
Net Profit
Higher at USD -47.7 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Here's what is not working for Applied Therapeutics, Inc.
Raw Material Cost
Grown by 107% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
